本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mereo Biopharma Group Plc

2.56
+0.06002.40%
盘后2.640.0800+3.13%17:20 EDT
成交量:261.15万
成交额:665.49万
市值:4.07亿
市盈率:-8.76
高:2.59
开:2.57
低:2.49
收:2.50
数据加载中...
2020/06/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/03/27

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/12

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/03/09

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/06

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/03/02

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/18

招股说明书

Registration statement for certain foreign private issuers
2020/02/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]